COLORADO DENVER UNIVERSITY OF

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Evaluating the Effects of Cannabis Use and Circulating Cannabinoids on Tumor Infiltrating Lymphocytes in Malignant Melanoma

Active, not recruiting

Conditions: Melanoma

Interventions: Other: High-performance liquid chromatography-tandem mass spectrometry assays

First Posted Date: 2022-08-29

Last Posted Date: 2024-04-17

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 90

Registration Number: NCT05520294

Locations: 🇺🇸
University of Colorado Denver, Aurora, Colorado, United States

Pre- and Post-operative TEG Indices in Patients With or Without Adenocarcinoma Undergoing Surgical Resection

Recruiting

Conditions: Lung Adenocarcinoma
Biliary Cancer
Control
Pancreas Cancer
Liver Cancer
Esophageal Cancer
Colorectal Cancer

Interventions: Diagnostic Test: TEG indices

First Posted Date: 2022-08-26

Last Posted Date: 2024-10-07

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 400

Registration Number: NCT05517811

Locations: 🇺🇸
University of Colorado Denver, Aurora, Colorado, United States

Pragmatic Trial of Metformin for Glucose Intolerance or Increased BMI in Prostate Cancer Patients

Early Phase 1

Recruiting

Conditions: Prostate Cancer

Interventions: Drug: Metformin
Behavioral: Lifestyle Modification

First Posted Date: 2022-08-25

Last Posted Date: 2024-08-29

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 200

Registration Number: NCT05515978

Locations: 🇺🇸
Colorado Research Center, Aurora, Colorado, United States
🇺🇸
UCHealth-Southern Colorado, Colorado Springs, Colorado, United States
🇺🇸
UCHealth-Metro Denver, Denver, Colorado, United States

and more 1 locations

Feasibility of Study of Empagliflozin in Patients With Autosomal Dominant Polycystic Kidney Disease

Phase 2

Recruiting

Conditions: Polycystic Kidney, Autosomal Dominant

Interventions: Drug: Placebo
Drug: Empagliflozin

First Posted Date: 2022-08-22

Last Posted Date: 2024-06-21

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 50

Registration Number: NCT05510115

Locations: 🇺🇸
University of Coloardo Anschutz Medical Campus, Aurora, Colorado, United States

Renal Mechanism of SGLT2 Inhibition

Phase 2

Recruiting

Conditions: Type 2 Diabetes
Diabetic Kidney Disease

Interventions: Drug: canagliflozin
Drug: Aminohippurate Sodium Inj 20%

First Posted Date: 2022-08-19

Last Posted Date: 2022-11-03

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 40

Registration Number: NCT05507892

Locations: 🇺🇸
University of Colorado Denver, Aurora, Colorado, United States
🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States
🇺🇸
University of Michigan, Ann Arbor, Michigan, United States

and more 1 locations

Establishing Guidelines for Manual Lymphatic Drainage

Not Applicable

Completed

Conditions: Lymphedema of Leg

Interventions: Procedure: Pressure

First Posted Date: 2022-08-19

Last Posted Date: 2024-01-11

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 64

Registration Number: NCT05509062

Locations: 🇺🇸
University of Colorado Anschutz Medical Campus, Aurora, Colorado, United States

Metabolomics Initiative: Mediterranean-amplified vs Habitual Western Diet on Food Signatures, Health, and Microbiome

Not Applicable

Active, not recruiting

Conditions: Dietary Habits

Interventions: Other: Semi-controlled dietary intervention - MiniMed
Other: Semi-controlled dietary intervention - Western

First Posted Date: 2022-08-15

Last Posted Date: 2024-08-27

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 22

Registration Number: NCT05500976

Locations: 🇺🇸
University of Colorado School of Medicine, Aurora, Colorado, United States

Interrogating Fatty Acid Metabolism Impairment and Clinical Correlates in Males with Klinefelter Syndrome

Phase 4

Active, not recruiting

Conditions: Klinefelter Syndrome

Interventions: Drug: Fenofibrate 145 mg

First Posted Date: 2022-08-11

Last Posted Date: 2024-10-16

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 44

Registration Number: NCT05498090

Locations: 🇺🇸
University of Colorado - Anschutz Medical Campus, Aurora, Colorado, United States

Use of Methazolamide to Lower Intraocular Pressure

Phase 4

Active, not recruiting

Conditions: Glaucoma, Open-Angle

Interventions: Drug: Methazolamide 50 MG
Drug: Methazolamide 25 MG

First Posted Date: 2022-08-11

Last Posted Date: 2024-02-06

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 30

Registration Number: NCT05498103

Locations: 🇺🇸
Sue Anschutz-Rodgers Eye Center, Aurora, Colorado, United States

Effect of Montelukast on Kidney and Vascular Function in Type 1 Diabetes

Phase 4

Recruiting

Conditions: Albuminuria

Interventions: Other: Placebo
Drug: Montelukast

First Posted Date: 2022-08-11

Last Posted Date: 2024-05-08

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 50

Registration Number: NCT05498116

Locations: 🇺🇸
University of Colorado Anschutz Medical Campus, Aurora, Colorado, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy